COVID-19
view channel
view channel
view channel
view channel
view channel
view channel
view channel
view channel
Clinical ChemistryMolecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyBioResearch
Events
- Pediatric CKD Progression Linked to Low Serum Bicarbonate
- Presepsin Values Evaluated as Sepsis Severity Markers
- Pregnancy TSH Variations Prompt Erroneous Thyroid Disease Diagnosis
- Biomarkers Evaluated for Lung Disease Severity in Cystic Fibrosis
- Metabolite Profiling Reveals Predictive Biomarkers for Amyotrophic Lateral Sclerosis
- DNA Sequencing Technique Unravels Genetic Diversity of Cancer Tumors
- An Eight MicroRNA Biomarker Panel for Diagnosis of ALS
- RNA Sequencing as Alternative to Immunohistochemistry in Cancer Diagnostics
- Blood Group Locus Contributes to COVID-19 Severity Risk
- Precision Medicine-Based Genetic Testing Developed for Prostate Cancer
- Detection Rate of Monoclonal Gammopathy of Undetermined Significance Determined
- Serum Mir‐22 Prognostic Marker Explored for Acute Myeloid Leukemia
- Tortuosity-Powered Microfluidic Device Assesses Thrombosis
- Cord Blood Transplants May Outperform Matched Sibling Donors
- Thromboelastography Identifies Undetected Blood Clots in COVID-19 Patients
- Blood Test Could Predict Multiple Sclerosis Progression
- Diagnostic Assay Developed for Unclassified Severe Combined Immune Deficiency
- Certain Cytokines Not Associated with Severity of COVID-19 Symptoms
- Increasingly Efficient Serological Tests Developed with Electrochemiluminescence
- Cytokine Signatures of Tertian Malaria Infection Profiled During Pregnancy
- Ultra-Fast Cycling for Multiplexed Cellular Fluorescence Imaging
- Esophageal Cancer Precursor Detected by Electronic Nose Device
- Analyzer Platform for Simultaneous Detection of Multiple Sexually Transmitted Infections Is Now CE-marked
- New Chemistry Analyzer Completes Ortho Clinical Diagnostics’ Catalogue of VITROS XT Solutions
- Global Blood Glucose Monitoring Devices Market to Reach USD 13 Billion by 2023
- Global ELISA Kits Market to Surpass USD 418.5 Billion by 2025
- Thermo Fisher Scientific to Acquire QIAGEN N.V.
- New AI System Performs as Well as Expert Pathologists in Identifying Prostate Cancer
- Quest Diagnostics Acquires Blueprint Genetics
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- Roche Advances Personalized Healthcare with Development of Image Analysis Algorithms Using Artificial Intelligence
- Precision Oncology Confers Clinical Benefit in Relapsed Pediatric Cancer
- Representative Tumor Sampling Method Lessens Molecular Analyses Bias
- Blood Test Shows Promise for Predicting Cancer
- Bacterial Blood Infections Tied to Heightened Colon Cancer Risk
COVID-19
- Pediatric CKD Progression Linked to Low Serum Bicarbonate
- Presepsin Values Evaluated as Sepsis Severity Markers
- Pregnancy TSH Variations Prompt Erroneous Thyroid Disease Diagnosis
- Biomarkers Evaluated for Lung Disease Severity in Cystic Fibrosis
- Metabolite Profiling Reveals Predictive Biomarkers for Amyotrophic Lateral Sclerosis
- DNA Sequencing Technique Unravels Genetic Diversity of Cancer Tumors
- An Eight MicroRNA Biomarker Panel for Diagnosis of ALS
- RNA Sequencing as Alternative to Immunohistochemistry in Cancer Diagnostics
- Blood Group Locus Contributes to COVID-19 Severity Risk
- Precision Medicine-Based Genetic Testing Developed for Prostate Cancer
- Detection Rate of Monoclonal Gammopathy of Undetermined Significance Determined
- Serum Mir‐22 Prognostic Marker Explored for Acute Myeloid Leukemia
- Tortuosity-Powered Microfluidic Device Assesses Thrombosis
- Cord Blood Transplants May Outperform Matched Sibling Donors
- Thromboelastography Identifies Undetected Blood Clots in COVID-19 Patients
- Blood Test Could Predict Multiple Sclerosis Progression
- Diagnostic Assay Developed for Unclassified Severe Combined Immune Deficiency
- Certain Cytokines Not Associated with Severity of COVID-19 Symptoms
- Increasingly Efficient Serological Tests Developed with Electrochemiluminescence
- Cytokine Signatures of Tertian Malaria Infection Profiled During Pregnancy
- Ultra-Fast Cycling for Multiplexed Cellular Fluorescence Imaging
- Esophageal Cancer Precursor Detected by Electronic Nose Device
- Analyzer Platform for Simultaneous Detection of Multiple Sexually Transmitted Infections Is Now CE-marked
- New Chemistry Analyzer Completes Ortho Clinical Diagnostics’ Catalogue of VITROS XT Solutions
- Global Blood Glucose Monitoring Devices Market to Reach USD 13 Billion by 2023
- Global ELISA Kits Market to Surpass USD 418.5 Billion by 2025
- Thermo Fisher Scientific to Acquire QIAGEN N.V.
- New AI System Performs as Well as Expert Pathologists in Identifying Prostate Cancer
- Quest Diagnostics Acquires Blueprint Genetics
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- Advanced Biological Releases First Commercial CE-IVD Registered COVID-19 rRT-PCR Assay Also Validated for Saliva
- BD Launches Portable, Rapid POC Antigen Test to Detect SARS-CoV-2 in 15 Minutes
- COVID-19-Influenza Combination Test Granted FDA Emergency Use Authorization
- Transasia Launches COVID-19 IgG Antibody Kits with 98% Accuracy and at 20% Cost of RT-PCR Tests
- Erba Mannheim Makes SARS-CoV-2 Testing Available to Labs Everywhere
- Roche Advances Personalized Healthcare with Development of Image Analysis Algorithms Using Artificial Intelligence
- Precision Oncology Confers Clinical Benefit in Relapsed Pediatric Cancer
- Representative Tumor Sampling Method Lessens Molecular Analyses Bias
- Blood Test Shows Promise for Predicting Cancer
- Bacterial Blood Infections Tied to Heightened Colon Cancer Risk
Client Login